(Total Views: 918)
Posted On: 12/04/2020 7:21:32 PM
Post# of 153917
Re: ClosetInvestor #67020
Quote:
Chiral Pharma Corporation, a subsidiary of Philippine New Marketlink Pharmaceutical Corporation (NMPC), to register leronlimab (PRO 140) for potential approval from the local Food and Drug Administration to treat patients with COVID-19 in the Philippines.
Doesn't exactly say "we applied for approval" but damn close. Again, different system over there, so you and I can parse and interpret the PR language all weekend, but Cytodyn could very well already be in the approval-pipeline.
(7)
(0)
